What Wall Street Analysts Think of Novo Nordisk's Stock Ahead of Earnings
Novo Nordisk(NVO) Investopedia·2024-11-04 21:30Key TakeawaysDanish pharmaceutical giant Novo Nordisk is set to report earnings for the third quarter of 2024 on Wednesday morning.Sales of its popular weight-loss drugs Ozempic and Wegovy will be Novo investors' focus.Analysts are generaly bullish on the stock, with five "hold" ratings and six "buy" ratings and an average price target about 28% above recent levels. Novo Nordisk (NVO), maker of popular weight-loss drugs Ozempic and Wegovy, is set to report third-quarter earnings Wednesday morning, with Wall ...